These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 17537383

  • 1. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M, Escárcega RO, Fuentes-Alexandro S, Riebeling C, Cervera R.
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravenous immune globulin in myasthenia gravis.
    Gajdos P.
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [Abstract] [Full Text] [Related]

  • 9. [Contribution of intravenous immunoglobulins to the treatment of myasthenia].
    Gajdos P.
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S30-4. PubMed ID: 10896986
    [Abstract] [Full Text] [Related]

  • 10. Treatment and clinical research in myasthenia gravis: how far have we come?
    Barohn RJ.
    Ann N Y Acad Sci; 2008 May; 1132():225-32. PubMed ID: 18567872
    [Abstract] [Full Text] [Related]

  • 11. The treatment of patients with myasthenia gravis.
    Sanders DB, Scoppetta C.
    Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
    [Abstract] [Full Text] [Related]

  • 12. Maintenance immunosuppression in myasthenia gravis.
    Gotterer L, Li Y.
    J Neurol Sci; 2016 Oct 15; 369():294-302. PubMed ID: 27653912
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of novel therapies for MG: Studies in animal models.
    Souroujon MC, Brenner T, Fuchs S.
    Autoimmunity; 2010 Aug 15; 43(5-6):446-60. PubMed ID: 20298126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.